Teresa Foy
Directeur/Bestuurslid bij NANOSTRING TECHNOLOGIES, INC.
Vermogen: 14 164 $ op 30-04-2024
Profiel
Teresa M.
Foy is an Independent Director at NanoString Technologies, Inc. and Senior VP-Immuno Oncology & Cell Therapy at Bristol Myers Squibb Co. She previously worked as Director-Preclinical Biology at Corixa Corp., Director-Preclinical Development at GlaxoSmithKline Biologicals NV, and Chief Scientific Officer at Oncofactor Corp.
She was also Senior Vice President-Research & Development at Viral Logic Systems Technology Corp.
from 2010 to 2012.
Foy holds a graduate degree from St. Cloud State University, a doctorate from the University of Iowa, and an undergraduate degree from the University of Minnesota.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 06-05-2024 | 55 091 ( 0.11% ) | 14 164 $ | 30-04-2024 |
Actieve functies van Teresa Foy
| Bedrijven | Functie | Begin |
|---|---|---|
| NANOSTRING TECHNOLOGIES, INC. | Directeur/Bestuurslid | 18-04-2022 |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 01-11-2019 |
Eerdere bekende functies van Teresa Foy
| Bedrijven | Functie | Einde |
|---|---|---|
Oncofactor Corp.
 Oncofactor Corp. Pharmaceuticals: MajorHealth Technology Oncofactor Corp. develops antibody drugs against new biologic targets in cancer. Its cancer therapeutics that disrupt signaling pathways between tumors and the immune system. The company was founded by Sarah Ellen Warren in 2011 and is headquartered in Seattle, WA. | Hoofd Techniek/Wetenschap/O&O | - |
GlaxoSmithKline Biologicals NV
 GlaxoSmithKline Biologicals NV BiotechnologyHealth Technology GlaxoSmithKline Biologicals SA manufactures vaccines for diseases such as hepatitis, influenza, rubella, and typhoid fever. Its activities include overall strategy, research and development, clinical trials, regulatory matters, production, quality control, marketing, and distribution. The company has partnership with WHO and UNICEF. GlaxoSmithKline Biologicals was founded in 1945 and is headquartered in Rixensart, Belgium. | Corporate Officer/Principal | - |
Corixa Corp.
 Corixa Corp. BiotechnologyHealth Technology Corixa Corp. operates as a biopharmaceutical company. It develops and manufactures oncology and immunology products. The firm offers vaccines, immunotherapeutic, monoclonal antibody-based therapeutics, adjuvant and antigen delivery systems, toxin-conjugated, and antigen-specific diagnostic products. The company was founded by Steven H. Gillis and Mark McDade in 1994 and is headquartered in Hamilton, MT. | Corporate Officer/Principal | - |
Viral Logic Systems Technology Corp.
 Viral Logic Systems Technology Corp. Pharmaceuticals: MajorHealth Technology Viral Logic Systems Technology Corp. provides pharmaceutical products and services. It develops treatments for autoimmune, inflammatory diseases and disorders. The company was founded by Steven R. Wiley and Craig A. Smith in 2004 and headquartered in Seattle, WA. | Hoofd Techniek/Wetenschap/O&O | - |
Opleiding van Teresa Foy
| University of Minnesota | Undergraduate Degree |
| University of Iowa | Doctorate Degree |
| St. Cloud State University | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| NANOSTRING TECHNOLOGIES, INC. | Health Technology |
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| Bedrijven in privébezit | 4 |
|---|---|
Viral Logic Systems Technology Corp.
Viral Logic Systems Technology Corp. Pharmaceuticals: MajorHealth Technology Viral Logic Systems Technology Corp. provides pharmaceutical products and services. It develops treatments for autoimmune, inflammatory diseases and disorders. The company was founded by Steven R. Wiley and Craig A. Smith in 2004 and headquartered in Seattle, WA. | Health Technology |
GlaxoSmithKline Biologicals NV
GlaxoSmithKline Biologicals NV BiotechnologyHealth Technology GlaxoSmithKline Biologicals SA manufactures vaccines for diseases such as hepatitis, influenza, rubella, and typhoid fever. Its activities include overall strategy, research and development, clinical trials, regulatory matters, production, quality control, marketing, and distribution. The company has partnership with WHO and UNICEF. GlaxoSmithKline Biologicals was founded in 1945 and is headquartered in Rixensart, Belgium. | Health Technology |
Corixa Corp.
Corixa Corp. BiotechnologyHealth Technology Corixa Corp. operates as a biopharmaceutical company. It develops and manufactures oncology and immunology products. The firm offers vaccines, immunotherapeutic, monoclonal antibody-based therapeutics, adjuvant and antigen delivery systems, toxin-conjugated, and antigen-specific diagnostic products. The company was founded by Steven H. Gillis and Mark McDade in 1994 and is headquartered in Hamilton, MT. | Health Technology |
Oncofactor Corp.
Oncofactor Corp. Pharmaceuticals: MajorHealth Technology Oncofactor Corp. develops antibody drugs against new biologic targets in cancer. Its cancer therapeutics that disrupt signaling pathways between tumors and the immune system. The company was founded by Sarah Ellen Warren in 2011 and is headquartered in Seattle, WA. | Health Technology |